Han Koo

581 total citations
16 papers, 454 citations indexed

About

Han Koo is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Han Koo has authored 16 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Han Koo's work include Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (3 papers) and Chemical Synthesis and Analysis (2 papers). Han Koo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (3 papers) and Chemical Synthesis and Analysis (2 papers). Han Koo collaborates with scholars based in South Korea and United States. Han Koo's co-authors include Nancy A. Staffend, Matthew W. VanBrocklin, Kathryn M. Eisenmann, George F. Vande Woude, Young Il Yeom, Stephen H. Leppla, Shahriar Koochekpour, James H. Resau, Nicholas S. Duesbery and Craig P. Webb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and JNCI Journal of the National Cancer Institute.

In The Last Decade

Han Koo

16 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han Koo South Korea	9	371	144	122	47	42	16	454
Ying‐Hui Ko United States	11	436 1.2×	327 2.3×	164 1.3×	39 0.8×	28 0.7×	15	678
Carol F. Franks United States	8	425 1.1×	144 1.0×	209 1.7×	25 0.5×	36 0.9×	10	640
Gabriela Koifman Israel	11	342 0.9×	150 1.0×	261 2.1×	20 0.4×	48 1.1×	12	486
Toshiya Kawaguchi Japan	7	399 1.1×	90 0.6×	122 1.0×	33 0.7×	28 0.7×	8	726
Jude Alsarraj United States	6	356 1.0×	115 0.8×	141 1.2×	25 0.5×	18 0.4×	6	469
Junfang Ji China	8	362 1.0×	113 0.8×	107 0.9×	32 0.7×	18 0.4×	11	478
Ningxi Zhu United States	10	433 1.2×	117 0.8×	224 1.8×	42 0.9×	24 0.6×	14	540
Anne Y. Saiki United States	10	337 0.9×	89 0.6×	282 2.3×	22 0.5×	31 0.7×	19	528
Lois Resnick‐Silverman United States	15	518 1.4×	97 0.7×	311 2.5×	45 1.0×	46 1.1×	18	728
Catherine A. Vaughan United States	14	355 1.0×	121 0.8×	330 2.7×	26 0.6×	74 1.8×	21	552

Countries citing papers authored by Han Koo

Since Specialization

Citations

This map shows the geographic impact of Han Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Koo more than expected).

Fields of papers citing papers by Han Koo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Koo. The network helps show where Han Koo may publish in the future.

Co-authorship network of co-authors of Han Koo

This figure shows the co-authorship network connecting the top 25 collaborators of Han Koo. A scholar is included among the top collaborators of Han Koo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Koo. Han Koo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Koo, Han, Kyung Chan Park, Hyun Ahm Sohn, et al.. (2025). Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development. Nature Communications. 16(1). 628–628. 1 indexed citations

Koo, Han, Hyejin Jeon, Minho Kang, et al.. (2024). Exosomal miR-196b secreted from bronchial epithelial cells chronically exposed to low-dose PM2.5 promotes invasiveness of adjacent and lung cancer cells. Toxicology Letters. 399. 9–18. 1 indexed citations

Park, Se Jin, Dong Chul Lee, Han Koo, et al.. (2023). Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivity. Non-coding RNA Research. 8(3). 273–281. 10 indexed citations

Cho, Jung Hee, et al.. (2022). LPIN1 Induces Gefitinib Resistance in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer Cells. Cancers. 14(9). 2222–2222. 1 indexed citations

Sohn, Hyun Ahm, Dong Chul Lee, Anna Park, et al.. (2022). Glycogen Storage Disease Phenotypes Accompanying the Perturbation of the Methionine Cycle in NDRG3-Deficient Mouse Livers. Cells. 11(9). 1536–1536. 1 indexed citations

Koo, Han, Sangwon Byun, Ji‐Eun Seo, et al.. (2021). PKM2 Regulates HSP90-Mediated Stability of the IGF-1R Precursor Protein and Promotes Cancer Cell Survival during Hypoxia. Cancers. 13(15). 3850–3850. 7 indexed citations

Yu, Seong‐Lan, Han Koo, Jaeku Kang, et al.. (2020). A Synthetic CPP33-Conjugated HOXA9 Active Domain Peptide Inhibits Invasion Ability of Non-Small Lung Cancer Cells. Biomolecules. 10(11). 1589–1589. 5 indexed citations

Yu, Seong‐Lan, Han Koo, Hoi Young Lee, et al.. (2019). Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion. Cellular Oncology. 42(3). 275–285. 10 indexed citations

Park, Young Soo, Dong Joon Kim, Han Koo, et al.. (2016). AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth. Oncotarget. 7(30). 48155–48167. 43 indexed citations

10.

Kim, Dong Joon, Young Soo Park, Nam Doo Kim, et al.. (2015). A Novel Pyruvate Kinase M2 Activator Compound that Suppresses Lung Cancer Cell Viability under Hypoxia. Molecules and Cells. 38(4). 373–379. 26 indexed citations

11.

Kim, Dong Joon, Young Soo Park, Han Koo, et al.. (2015). Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells. Experimental Cell Research. 336(1). 119–129. 48 indexed citations

12.

Eisenmann, Kathryn M., et al.. (2003). Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein bad.. PubMed. 63(23). 8330–7. 120 indexed citations

13.

Duesbery, Nicholas S., James H. Resau, Craig P. Webb, et al.. (2001). Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proceedings of the National Academy of Sciences. 98(7). 4089–4094. 80 indexed citations

14.

Koo, Han, Glenda Kohlhagen, Mary Jane McWilliams, et al.. (1999). The ras Oncogene-Mediated Sensitization of Human Cells to Topoisomerase II Inhibitor-Induced Apoptosis. JNCI Journal of the National Cancer Institute. 91(3). 236–244. 28 indexed citations

15.

Koo, Han, Anne Monks, Andrei M. Mikheev, et al.. (1996). Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes.. PubMed. 56(22). 5211–6. 72 indexed citations

16.

Lee, Young Woo, et al.. (1992). Chromosomal Translocation Occuring Congenital Coloboma in Both Eyes.. Journal of the Korean Ophthalmological Society. 33(12). 1233–1237. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact